Free Trial
NASDAQ:DCGO

DocGo Q1 2026 Earnings Report

DocGo logo
$0.68 +0.01 (+1.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.68 +0.00 (+0.18%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DocGo EPS Results

Actual EPS
N/A
Consensus EPS
-$0.02
Beat/Miss
N/A
One Year Ago EPS
N/A

DocGo Revenue Results

Actual Revenue
N/A
Expected Revenue
$72.48 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

DocGo Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Monday, May 11, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

DocGo Earnings Headlines

$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel
See More DocGo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DocGo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DocGo and other key companies, straight to your email.

About DocGo

DocGo (NASDAQ:DCGO), Inc. is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging. The company also partners with public health agencies, employers, universities and event organizers to administer diagnostic testing services for COVID-19 and other infectious diseases. By integrating telehealth, remote patient monitoring and mobile diagnostic capabilities, DocGo aims to streamline access to care, reduce strain on traditional facilities and improve patient outcomes.

DocGo became a publicly traded company in June 2021 following a business combination with SPAC sponsor GigCapital3 Inc., trading on the Nasdaq under the ticker DCGO. Headquartered in Austin, Texas, the company has expanded its reach across multiple U.S. markets, including metropolitan areas in California, Florida, Texas and New York. DocGo’s on-demand approach leverages technology and logistics to enhance convenience, affordability and quality of care for both urban and rural communities.

View DocGo Profile